Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia

Thrombosis Research
Margaret PrechelJeanine M Walenga

Abstract

Many heparin-induced thrombocytopenia (HIT) antibodies cause platelet activation in the serotonin release assay (SRA) in the absence of heparin. This in vitro observation may help unravel the mechanism of delayed-onset HIT, where seropositive patients develop thrombocytopenia and associated thrombosis after cessation of heparin. Studies were conducted to examine the relationship between platelet environment, surface PF4 expression, and the extent of heparin-independent platelet activation in the SRA. Ex vivo platelets were washed and labeled for SRA, then used either before or after 45 minutes of recovery at 37 degrees C. HIT antibody-mediated serotonin release in the absence of heparin was compared to the extent of surface staining of the platelets with fluorescent anti-human PF4 antibodies. Handling of platelets for in vitro studies resulted in transient expression of surface PF4, and it was during this interval that platelets were most sensitive to activation by HIT antibodies in the absence of heparin. Heparin-independent platelet activation was attenuated when SRA-positive specimens were retested after platelets were incubated 45 minutes at 37 degrees C. Surface PF4 expression was diminished on the rested platelets, compar...Continue Reading

References

Jan 1, 1985·Seminars in Thrombosis and Hemostasis·D A Walz, G L Hung
Apr 17, 1985·Biochimica Et Biophysica Acta·A M CapitanioE Kornecki
Jul 1, 1982·Thrombosis Research·J DawesD S Pepper
Jun 1, 1995·Journal of the American Society of Nephrology : JASN·A SainiB S Ooi
Mar 15, 1996·Thrombosis Research·C B ReiningerL Schweiberer
Jun 23, 1999·The American Journal of Medicine·D E WallisJ F Moran
Dec 3, 1999·British Journal of Haematology·P M Newman, B H Chong
Apr 17, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·E Maurer-SpurejD V Devine
Oct 2, 2001·Annals of Internal Medicine·T E Warkentin, J G Kelton
Feb 6, 2002·Annals of Internal Medicine·Lawrence RiceJohn L Francis
Jun 30, 2004·American Journal of Hematology·Lucie Opatrny, Margaret N Warner
Jul 30, 2004·Anesthesia and Analgesia·Helge SchoenfeldHartmut Radtke
Mar 22, 2005·The International Journal of Biochemistry & Cell Biology·Arne Slungaard
Aug 18, 2005·Seminars in Thoracic and Cardiovascular Surgery·Mortimer Poncz
Sep 12, 2006·Journal of Thrombosis and Haemostasis : JTH·M P ReillyS E McKenzie
Jan 30, 2007·Hematology/oncology Clinics of North America·Jerrold H Levy, Marcie J Hursting
Sep 13, 2007·Blood·Shayela SuvarnaGowthami M Arepally
Oct 25, 2007·Journal of Thrombosis and Haemostasis : JTH·I SocherU J H Sachs
Apr 9, 2008·Seminars in Thrombosis and Hemostasis·Margaret Prechel, Jeanine M Walenga
Nov 28, 2008·Blood·Giannoula Lakka KlementJudah Folkman

❮ Previous
Next ❯

Citations

Apr 25, 2012·Journal of Biomedical Materials Research. Part a·Achala de MelAlexander M Seifalian
Jul 25, 2012·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Reiko AsadaMiyako Matsuo
Nov 19, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Maxime DoréDavid Williamson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.